Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of <i>N</i>-(((1<i>r</i>,4<i>r</i>)-4-((6-fluorobenzo[<i>d</i>]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist

• Hauptverfasser: Hironori Tanaka (Verfasst von), Hiroshi Ueda (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2024-10-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

<b>Background/Objectives:</b> Brick dust molecules exhibit high melting points and ultralow solubility. Overcoming this solubility issue is challenging. Previously, we formulated a co-amorphous system for a neuropeptide Y5 receptor antagonist (NP) as a brick dust drug using sodium tauroc...